Explore Biology at the Level of Single-Cells with High Precision, Speed, and Throughput
ABOUT US
Single-Cell Microfluidics and Advanced Technologies
Acoustic Bio is an early-stage company pioneering technologies to scale and accelerate single-cell screening workflow. Our platform integrates microfluidics, live-cell imaging, novel acoustic technology, and machine learning to empower biologists to discover bioproducts in a fraction of the time and cost of traditional methods.
Miniaturization
High-Throughput Discovery
Innovative Acoustic Technology
Accelerates workflows from
weeks to hours
Screen up to a million cells per day
Transform room-scale automation to a miniaturized device that operates at the level of single cells

PIONEERING SOLUTIONS
Extensive
Application Potential

Functional Genomics
High-throughput screening of CRISPR edited cells (mammalian and yeast)

Immune Single-Cell Profiling
Phenotypic and functional screening of B-cells and T-cells

Synthetic Biology
Test large number of genetic variants faster and more efficiently

Emerging Applications
Cell therapy (engineered stem cell and T-Cells)
How it works
A simple, yet powerful platform for screening cell function at the level of single-cells

INNOVATION IN ACTION
Acoustic Retrieval
Real-time video of acoustic retrieval of live individual GFP expressing Raji cells from individual nanowells
Acoustic Bio
MEET THE TEAM
We are a group of technologists working at the intersections of engineering and biology to build a novel platform to accelerate single-cell analysis. The team has extensive experience in commercialization of microfluidic imaging systems.
TEAM MEMBERS
Bahram Fathollahi, PhD Founder & CEO
- 20+ years R&D leader in commercialization of Microfluidic Platforms, established partnership with pharma on technology adoption
- Grew revenue from $25M to $150M. Caliper acquired by PerkinElmer for $750M
Dan Stearns, PhD Founder & CTO
- 25+ years R&D leader in commercialization of Biological Imaging Systems
- Xenogen acquired by Caliper Lifesciences for $80M
Jay WhalenDirector of Engineering
David PeisleySenior Systems Engineer
SCIENTIFIC ADVISORS
Join US
Career
Opportunities
Contact Us
We are open to explore strategic partnerships on the use of our platform for novel bioproduct discovery